CalciMedica, Inc. , a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs.
Calcimedica stock last closed at $0.74, down 10.22% from the previous day, and has decreased 63.82% in one year. It has underperformed other stocks in the Biotechnology industry by 0.19 percentage points. Calcimedica stock is currently +60.09% from its 52-week low of $0.46, and -89.75% from its 52-week high of $7.20.
As of Mar 19, 2026, there are 15.74M shares of CALC outstanding. The market cap of CALC is $11.62M. In the last 24 hours, 308,000 CALC shares were traded.
You need a brokerage account to access the NASDAQ market and buy CALC stock.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, it's time to fill out some personal info so you are able to buy CALC stock today.
Now that you have opened your account on stock market apps, you need to deposit funds:
Watch the tutorial below to see the process of transferring funds into your new brokerage account.
Once you have decided on the best place to buy Calcimedica stock, it's very important to analyze their stock before you buy, so you actually wrap your head around the risk and opportunity.
WallStreetZen was created to help part-time investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on CALC's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge CALC's true value.
You can access more valuation research on CALC's stock here.
Out of 1 Wall Street analysts who track CALC, the consensus analyst rating on Calcimedica is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Calcimedica stock forecast page.
In the last year, insiders at CALC have bought more shares than they have sold.
Eric W. Roberts, CHIEF BUSINESS OFFICER of CALC, was the latest CALC insider to buy. They bought $7,675.00 worth of CALC stock on Sep 18, 2025.
Get more info about who owns CALC stock here.
No, Calcimedica doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two main order types:
Hit the Open button and eToro will place the order.
If you need more help with buying stocks on eToro, click the helpful video below:
Now that you own some shares in CALC, you'll want to stay up-to-date on your investment.
Add CALC to a watchlist to track the most important metrics related to your CALC stock.
To reiterate, here are the 6 steps to buy Calcimedica stock:
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your investment in Calcimedica, create a watchlist on WallStreetZen today.